310
Views
30
CrossRef citations to date
0
Altmetric
Review

Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States

Pages 947-957 | Published online: 03 Jul 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Grace S. Hubel & Angela D. Moreland. (2020) What do adolescent parents need to prevent repeat pregnancy? A qualitative investigation. Vulnerable Children and Youth Studies 15:1, pages 21-31.
Read now
I. Piva, F. Brusca, F. Tassinati, S. Bonipozzi, A. Palano, M. T. Sassi, G. Bonaccorsi, D. Morano, R. Martinello, G. Scutiero, U. Indraccolo & P. Greco. (2019) Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant. Gynecological Endocrinology 35:5, pages 427-433.
Read now
Sally Rafie, Rebecca H Stone, Tracey A Wilkinson, Laura M Borgelt, Shareen Y El-Ibiary & Denise Ragland. (2017) Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. Integrated Pharmacy Research and Practice 6, pages 99-108.
Read now

Articles from other publishers (27)

Iason Psilopatis, Kleio Vrettou, Florian Nima Fleckenstein & Stamatios Theocharis. (2023) The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities. Cells 12:9, pages 1227.
Crossref
Casandra Dolovich, Leigh Anne Shafer, Lesley A. Graff, Kathy Vagianos, Kelcie Witges, Laura E. Targownik & Charles N. Bernstein. (2023) Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD. Journal of Clinical Gastroenterology Publish Ahead of Print.
Crossref
Suraj Fanse, Quanying Bao & Diane J. Burgess. (2022) Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. Advanced Drug Delivery Reviews 191, pages 114581.
Crossref
Karina Castillo, Kevin Zambrano, Diego Barba, Paola Robayo, Serena Sanon, Andres Caicedo & Alfredo Jose Jijon Chiriboga. (2022) Long-acting reversible contraceptives effects in abnormal uterine bleeding, a review of the physiology and management. European Journal of Obstetrics & Gynecology and Reproductive Biology 270, pages 231-238.
Crossref
Rita Palmeira-de-Oliveira, Ana Sofia Oliveira, Joana Rolo, Mariana Tomás, Ana Palmeira-de-Oliveira, Sérgio Simões & José Martinez-de-Oliveira. (2022) Women’s preferences and acceptance for different drug delivery routes and products. Advanced Drug Delivery Reviews 182, pages 114133.
Crossref
Bi Jiang, Wei-Chao He, Jing-Yun Yu, Si-Si Wei & Xin-Jian Zhang. (2021) History of IUD utilization and the risk of preterm birth: a cohort study. Archives of Gynecology and Obstetrics 305:2, pages 349-358.
Crossref
Kidane G. Haileyes, Hussen M. Asfaw, Siraye G. Ayele & Leul D. Kitawu. (2023) Myth and misconception about long-acting reversible contraception use among reproductive age group women in Debre Berhan governmental health centers, Ethiopia: qualitative study. Global Reproductive Health 8:1, pages e65-e65.
Crossref
Sarah G. Franklin, Maya O’Neal, Ambreanna Arneus, Calvin Colvin, Maung Aung & Pauline E. Jolly. (2021) Effectiveness of an intrauterine device informative intervention among post-natal women in Western Jamaica. Reproductive Health 18:1.
Crossref
Zaida Urbán-Morlán, Luis Eduardo Serrano-Mora, Lizbeth Martínez-Acevedo, Gerardo Leyva-Gómez, Néstor Mendoza-Muñoz & David Quintanar-Guerrero. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems 601 622 .
Ziliang Wang, Wei Yuan, Xiaowen Tu, Hong Liang, Maohua Miao, Yan Cheng, Longmei Jin & Chaohua Lou. (2020) Misconceptions and Beliefs Regarding the Use of Intrauterine Devices for Nulliparous Women Among Chinese Health Care Providers. Journal of Pediatric and Adolescent Gynecology 33:1, pages 33-38.
Crossref
OluwasomidoyinO Bello & AdebayoD Agboola. (2020) Trends in contraceptive uptake at a tertiary health facility in Ibadan, Nigeria. International Journal of Medicine and Health Development 25:1, pages 21.
Crossref
Ziliang Wang, Chaohua Lou, Longmei Jin, Maohua Miao, Xiaowen Tu, Hong Liang, Yan Cheng & Wei Yuan. (2019) Attitudes and practices related to intrauterine devices for nulliparous women among Chinese health care providers. Reproductive Health 16:1.
Crossref
Mohammad S. Alyahya, Heba H. Hijazi, Hussam A. Alshraideh, Nihaya A. Al-sheyab, Dana Alomari, Sara Malkawi, Sarah Qassas, Samah Darabseh & Yousef S. Khader. (2019) Do modern family planning methods impact women’s quality of life? Jordanian women’s perspective. Health and Quality of Life Outcomes 17:1.
Crossref
Michelle Lende, Emily Freeman, Rakin Hoq, Connie Cottrell & Jennifer Savitski. (2019) Multidisciplinary Approach to Managing an Obstetrical Patient with Delusional Denial of Pregnancy. Psychiatric Annals 49:11, pages 506-508.
Crossref
Pauline Bosco-Lévy, Amandine Gouverneur, Claire Langlade, Ghada Miremont & Antoine Pariente. (2019) Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Contraception 99:6, pages 345-349.
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2020) Potential for Improving Intrauterine Device (IUD) Service Delivery Quality: Results from a Secondary Data Analysis. Gates Open Research 3, pages 1473.
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2019) Could EAISI-trained providers provide better quality of IUD services? Results of a secondary data analysis of complications as a proxy indicator. Gates Open Research 3, pages 1473.
Crossref
Manish Gehani, Manoj Pal, Anupama Arya, Shobhana Singh, Kaushik S., Kathryn A. O’Connell, Levent Cagatay, Sumon Sengupta & Sunita Singal. (2019) Could trained providers provide better quality of IUD services? Results of a secondary data analysis of complications as a proxy indicator. Gates Open Research 3, pages 1473.
Crossref
Fred Yao Gbagbo & Esinam Afi Kayi. (2018) Use and discontinuation of intrauterine contraceptive device in the Greater Accra Region of Ghana. Contraception and Reproductive Medicine 3:1.
Crossref
Iliescu Dominic Gabriel, Ștefania Tudorache, Simona Vlădăreanu, Nuți Daniela Oprescu, Maria Cezara Mureșan, Roxana Cristina Drăgușin & Iuliana Ceaușu. 2018. Family Planning. Family Planning.
Nancy Fugate Woods & Gloria Bachmann. (2017) Contraception for midlife women: lack of information? Lack of interest? Lack of investment?. Women's Midlife Health 3:1.
Crossref
Justine P. Wu, Michael M. McKee, Kimberly S. Mckee, Michelle A. Meade, Melissa Plegue & Ananda Sen. (2017) Female sterilization is more common among women with physical and/or sensory disabilities than women without disabilities in the United States. Disability and Health Journal 10:3, pages 400-405.
Crossref
David K. Turok, David L. Eisenberg, Stephanie B. Teal, Lisa M. Keder & Mitchell D. Creinin. (2016) A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement. American Journal of Obstetrics and Gynecology 215:5, pages 599.e1-599.e6.
Crossref
Cary C. Cotton, Donna Baird, Robert S. Sandler & Millie D. Long. (2016) Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis. Inflammatory Bowel Diseases 22:7, pages 1631-1638.
Crossref
Kim Angelini. (2016) A Lower-Cost Option for Intrauterine Contraception. Nursing for Women's Health 20:2, pages 197-202.
Crossref
Ignacio Cristobal, Luis Ignacio Lete, Esther de la Viuda, Nuria Perulero, Agnes Arbat & Ignasi Canals. (2016) One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users. Contraception 93:4, pages 367-371.
Crossref
David L. Eisenberg, Courtney A. Schreiber, David K. Turok, Stephanie B. Teal, Carolyn L. Westhoff & Mitchell D. Creinin. (2015) Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception 92:1, pages 10-16.
Crossref